Skip to main content
Clinical Trials/ITMCTR1900002585
ITMCTR1900002585
Not yet recruiting
未知

Clinical evaluation of acupuncture effects based on the theory of Meridian-Viscera Association

Chengdu University of Traditional Chinese Medicine0 sitesTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Chengdu University of Traditional Chinese Medicine
Status
Not yet recruiting
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Interventional study
Sex
All

Investigators

Sponsor
Chengdu University of Traditional Chinese Medicine

Eligibility Criteria

Inclusion Criteria

  • 1\. Matching the diagnostic criteria of CSAP according to the Chinese Society of Cardiology;
  • 2\. Meeting Class I or II of the Canadian Cardiovascular Society (CCS) angina pectoris severity grade;
  • 3\. Aging from 45 to 70 years;
  • 4\. Having experienced angina attack in at least the last three months, and the attack frequency \>\= twice a week in the most recent month;
  • 5\. At least 2 months of standardized medication history before enrolment (sustaining the same medication, usage, and dose). Basic therapeutic drug is one or more of the following: ß\-blockers, angiotensin converting enzyme inhibitors (ACEIs), angiotensin II receptor blockers(ARB), antiplatelet medications and statins;
  • 6\. Having signed informed consent.

Exclusion Criteria

  • 1\. Being pregnant or during lactation or intending to be pregnant in the 6 months;
  • 2\. Having severe cardiovascular, digestive, urinary, respiratory, hematological, nervous, or endocrine system diseases that cannot be controlled with clinical treat\-ments;
  • 3\. Converting to acute coronary syndrome (including acute myocardial infarction and unstable angina pectoris), serious arrhythmia (advanced atrioventricular block, ventricular tachycardia, supraventricular tachycardia, frequent premature beats);
  • 4\. Being accompanied with serious psychiatric illness;
  • 5\. Failing to control hypertension (systolic blood pressure \>\= 140 mm Hg and/or diastolic blood pressure \>\= 90 mm Hg) or diabetes mellitus (HbA1 above 7% in last three months);
  • 6\. Having received acupuncture therapy due to cardiovascular illness in the last 1 month;
  • 7\. Having bleeding tendency and dermatitis;
  • 8\. Being in allergic constitution and be allergic to adhesive tape;
  • 9\. Participating in any other clinical trials.

Outcomes

Primary Outcomes

Not specified

Similar Trials